What does DR. VERMEIJ NEUROLOGIE do?

DR. VERMEIJ NEUROLOGIE is a specialist medical practice in Heusden-Zolder. Private Limited, started on 3 December 2019, 1 establishment.

What is the address of DR. VERMEIJ NEUROLOGIE?

The registered office of DR. VERMEIJ NEUROLOGIE is located at Sterrenwacht 74, 3550 Heusden-Zolder.

Is DR. VERMEIJ NEUROLOGIE still active?

Yes. According to the CBE (18 September 2026) DR. VERMEIJ NEUROLOGIE is active, legal situation “Normale toestand”, started on 3 December 2019.

Is DR. VERMEIJ NEUROLOGIE registered on Peppol?

Yes, DR. VERMEIJ NEUROLOGIE is registered on the Peppol network with ID 0208:0738701223.

What is the enterprise number of DR. VERMEIJ NEUROLOGIE?

The enterprise number of DR. VERMEIJ NEUROLOGIE is BE0738701223.

When was DR. VERMEIJ NEUROLOGIE founded?

DR. VERMEIJ NEUROLOGIE was founded on 3 December 2019.

Who are the directors of DR. VERMEIJ NEUROLOGIE?

According to the 2025 annual accounts, the directors of DR. VERMEIJ NEUROLOGIE are: Jan-Dirk Vermeij.

Is DR. VERMEIJ NEUROLOGIE a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 3 December 2019; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did DR. VERMEIJ NEUROLOGIE make in 2025?

DR. VERMEIJ NEUROLOGIE posted a profit after taxes of € 132,456 in financial year 2025.

What is the revenue of DR. VERMEIJ NEUROLOGIE?

As a small company, DR. VERMEIJ NEUROLOGIE is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 195,912.

DR. VERMEIJ NEUROLOGIE (Private Limited) - Heusden-Zolder

Dossier DR. VERMEIJ NEUROLOGIE, printed on 18 September 2026 from databakkes.be/en/0738701223/dr-vermeij-neurologie. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

DR. VERMEIJ NEUROLOGIE from Heusden-Zolder, company number BE0738701223, closed financial year 2025 with a result of € 132,456 after tax. For that financial year DR. VERMEIJ NEUROLOGIE recorded a gross margin of € 195,912 and equity of € 40,564. Compared with financial year 2024, the result moved from € 83,892 to € 132,456. Profitable, and profit is growing. The buffer shrank hard: equity is 67 % below last year. Debts are under control. The most recent annual accounts were filed with the National Bank of Belgium on June 18, 2026.

What it is worth Shrank hard

€ 40,564

▼ 67% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 132,456

▲ 58% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 54,609

▼ 33% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 216,348 paid out

More than the year’s profit went to the shareholders; reserves fell.

People and assets in 2025

Full-time equivalents estimate The annual accounts report no full-time equivalents. A micro company with one active director is usually run by that person; this is an assumption, not a figure from the source.

≈ 1

No payroll staff. One director, so that person most likely runs the business.

Vehicles and equipment

€ 38,941

▼ 23% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt ≈ 1 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 28,395

▼ 26% vs 2024

€ 19,688 is repaid this year. At this pace the long-term loan is gone in ≈ 1 years.

Owed to suppliers

€ 2,248

▼ 60% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 19,048

▲ 290% vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 52,238 Gross margin 2022: € 52,238 First fiscal year in the series	€ 61,293 Gross margin 2023: € 61,293 ▲ 17% vs 2022 (€ 52,238) Favourable step	€ 133,147 Gross margin 2024: € 133,147 ▲ 117% vs 2023 (€ 61,293) Favourable step	€ 195,912 Gross margin 2025: € 195,912 ▲ 47% vs 2024 (€ 133,147) Favourable step	▲ 47%
Profit after taxes	€ 36,135 Profit after taxes 2022: € 36,135 First fiscal year in the series	€ 36,863 Profit after taxes 2023: € 36,863 ▲ 2% vs 2022 (€ 36,135) Favourable step	€ 83,892 Profit after taxes 2024: € 83,892 ▲ 128% vs 2023 (€ 36,863) Favourable step	€ 132,456 Profit after taxes 2025: € 132,456 ▲ 58% vs 2024 (€ 83,892) Favourable step	▲ 58%
Equity	€ 147,322 Equity 2022: € 147,322 First fiscal year in the series	€ 78,185 Equity 2023: € 78,185 ▼ 47% vs 2022 (€ 147,322) Unfavourable step	€ 124,457 Equity 2024: € 124,457 ▲ 59% vs 2023 (€ 78,185) Favourable step	€ 40,564 Equity 2025: € 40,564 ▼ 67% vs 2024 (€ 124,457) Unfavourable step	▼ 67%
Total debts	€ 23,895 Total debts 2022: € 23,895 First fiscal year in the series	€ 143,843 Total debts 2023: € 143,843 ▲ € 119,948 vs 2022 (€ 23,895) Unfavourable step	€ 112,191 Total debts 2024: € 112,191 ▼ 22% vs 2023 (€ 143,843) Favourable step	€ 188,080 Total debts 2025: € 188,080 ▲ 68% vs 2024 (€ 112,191) Unfavourable step	▲ 68%
Cash	€ 46,954 Cash 2022: € 46,954 First fiscal year in the series	€ 50,862 Cash 2023: € 50,862 ▲ 8% vs 2022 (€ 46,954) Favourable step	€ 81,149 Cash 2024: € 81,149 ▲ 60% vs 2023 (€ 50,862) Favourable step	€ 54,609 Cash 2025: € 54,609 ▼ 33% vs 2024 (€ 81,149) Unfavourable step	▼ 33%
Retained profit	€ 139,322 Retained profit 2022: € 139,322 First fiscal year in the series	€ 70,185 Retained profit 2023: € 70,185 ▼ 50% vs 2022 (€ 139,322) Unfavourable step	€ 116,457 Retained profit 2024: € 116,457 ▲ 66% vs 2023 (€ 70,185) Favourable step	€ 32,564 Retained profit 2025: € 32,564 ▼ 72% vs 2024 (€ 116,457) Unfavourable step	▼ 72%
Dividend	€ 0 Dividend 2022: € 0 First fiscal year in the series	€ 106,000 Dividend 2023: € 106,000 Unchanged (€ 0) Unchanged	€ 37,621 Dividend 2024: € 37,621 ▼ 65% vs 2023 (€ 106,000) Unchanged	€ 216,348 Dividend 2025: € 216,348 ▲ € 178,728 vs 2024 (€ 37,621) Unchanged	▲ € 178,728
Bank debt	€ 14,332 Bank debt 2022: € 14,332 First fiscal year in the series	€ 54,441 Bank debt 2023: € 54,441 ▲ 280% vs 2022 (€ 14,332) Unfavourable step	€ 38,352 Bank debt 2024: € 38,352 ▼ 30% vs 2023 (€ 54,441) Favourable step	€ 28,395 Bank debt 2025: € 28,395 ▼ 26% vs 2024 (€ 38,352) Favourable step	▼ 26%
Balance sheet total	€ 171,218 Balance sheet total 2022: € 171,218 First fiscal year in the series	€ 222,028 Balance sheet total 2023: € 222,028 ▲ 30% vs 2022 (€ 171,218) Unchanged	€ 236,647 Balance sheet total 2024: € 236,647 ▲ 7% vs 2023 (€ 222,028) Unchanged	€ 228,645 Balance sheet total 2025: € 228,645 ▼ 3% vs 2024 (€ 236,647) Unchanged	▼ 3%

Key figures of DR. VERMEIJ NEUROLOGIE, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to DR. VERMEIJ NEUROLOGIE?

What happened at DR. VERMEIJ NEUROLOGIE in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jun 18, 2026 New annual accounts for financial year 2025: profit of € 132,456 (▲ 58% vs 2024). Source: NBB ↗
Dec 3, 2019 New establishment in Heusden-Zolder. KBO
Dec 3, 2019 Start of the company according to the CBE. KBO

In short

From € 36,135 profit in 2022 to € 132,456 profit in 2025.

Paid € 81,903 in corporate taxes since 2022.

Best year ever: 2025, with € 132,456 profit.

Paid out € 359,969 in dividends to the owners in total.

Original PDFs at the National Bank ↗

A new publication or filing at DR. VERMEIJ NEUROLOGIE? We notify you, reason included.

Follow DR. VERMEIJ NEUROLOGIE

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit

Real filings at the National Bank

Management

Jan-Dirk Vermeij

DR. VERMEIJ NEUROLOGIE

Behind DR. VERMEIJ NEUROLOGIE is Jan-Dirk Vermeij.

See the full network in the app

Directors

According to the 2025 annual accounts

Jan-Dirk Vermeij

Director

Establishments

Establishment units

Physical locations of this company

Registered office

Sterrenwacht 74

3550 Heusden-Zolder

2.297.166.074

Hertenlaan 20

3550 Heusden-Zolder

Active since 3 December 2019

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0738.701.223
VAT number: BE 0738.701.223
Registered office: Sterrenwacht 74, 3550 Heusden-Zolder
Names & denominations: DR. VERMEIJ NEUROLOGIE
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 3 December 2019
Peppol: Active · Active since 1 Jan 2001
Activities · NACE: Activiteiten van medisch specialisten

View on CBE Public ↗ Annual accounts (NBB) ↗